Endoscopic Adenoidectomy Secondary to Druginduced Trismus

Mark Greenberg, Daniela Carvalho
DOI: 10.4236/ss.2010.11006                

Abstract

We present the case of a 4 year old girl whose adenoidectomy had to be performed via an endoscopictrans oral approach due to the unexpected inability to fully open the mouth during the procedure. The patient had previously been taking Risperidone for behavioral symptoms associated with her autism. The jaw tone returned to normal following the procedure and there were no complications. An interaction between the Risperidone and the anesthetics were the likely cause of the trismus.

Keywords

Adenoidectomy, Endoscopic, Trismus, Risperidone, Masseter Spasm

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	M. B. Ugur, S. M. Dogan, A. Sogut, L. Uzun, F. Cinar, R. Altin and M. Aydin, “Effect of Adenoidectomy and/or Tonsillectomy on Cardiac Functions in Children with Obstructive Sleep Apnea,” Journal of OtoRhinoLaryngology and its Related Specialties, Vol. 70, No. 3, 2008, pp. 202208.
[2]	F. Pagella, E. Matti, A. Colombo, G. Giourgos and E. Mira, “How We do it: A Combined Method of Traditional Curette and PowerAssisted Endoscopic Adenoidectomy,” Acta Otolaryngol, Vol. 129, No. 5, 2009 May, pp. 556559.
[3]	K. A. AlMazrou, A. AlQahtani and A. I. AlFayez, “Effectiveness of transnasal endoscopic powered adenoidectomy in patients with choanal adenoids,” International Journal of Pediatric Otorhinolaryngology, Vol. 73, No. 12, December 2009, pp. 16501652.
[4]	Y. H. Jong and B. S. Gendeh, “Transoral Endoscopic Adenoidectomy: Initial Experience,” The Medical Journal of Malaysia, Vol. 63, No. 1, March 2008, pp. 8183.
[5]	G. Dhanasekar, A. Liapi and N. Turner, “Adenoidectomy Techniques: UK Survey,” The Journal of Laryngology & Otology, Vol. 30, 2009, pp. 15.
[6]	R. P. Malone and A. Waheed, “The Role of Antipsychotics in the Management of Behavioural Symptoms in Children and Adolescents with Autism,” Drugs, Vol. 69, No. 5, 2009, 535548.
[7]	R. Canitano and V. Scandurra, “Risperidone in the Treatment of Behavioral Disorders Associated with Autism in Children and Adolescents,” Journal of Neuropsychiatric Disease and Treatment, Vol. 4, No. 4, August 2008, 723730.
[8]	L. J. Scott and S. Dhillon, “Risperidone: A Review of its Use in the Treatment of Irritability Associated with Autistic Disorder in Children and Adolescents,” Paediatr Drugs, Vol. 9, No. 5, 2007, pp. 343354.
[9]	M. A. Willemsen and K. G. van der Wal, “MedicationInduced Mandibular Luxation in a SevenYearOld Patient,” Tijdschr Psychiatr, Vol. 50, No. 1, 2008, pp. 6164.
[10]	R. Sharma, B. Trappler, Y. K. Ng and C. P. Leeman, “RisperidoneInduced Neuroleptic Malignant Syndrome,” The Annals of Pharmacotherapy, JulyAugust 1996, Vol. 30, No. 78, pp. 775778.
[11]	J. A. Ramirez, E. D. Cheetham, A. S. Laurence and P. M. Hopkins, “Suxamethonium, Masseter Spasm and Later Malignant Hyperthermia,” Anaesthesia, November 1998; Vol. 53, No. 11, pp. 11111116.
[12]	J. R. Kosko, B. W. Brandom and K. H. Chan, “Masseter Spasm and Malignant Hyperthermia: A Retrospective Review of a HospitalBased Pediatric Otolaryngology Practice,” International Journal of Pediatric Otorhinolaryngology, January 1992, Vol. 23, No. 1, pp. 4550.
[13]	P. G. Monroy and M. A. “Da Fonseca the Use of Botulinum ToxinA in the Treatment of Severe Bruxism in a Patient with Autism: A Case Report,” Spec Care Dentist, Vol. 26, No. 1, 2006, pp. 3739.